ESC 365 - The efficacy and safety of simvastatin-fenofibrate fixed-dose combination in patients undergoing percutaneous coronary intervention

ACNAP Premium Access

The efficacy and safety of simvastatin-fenofibrate fixed-dose combination in patients undergoing percutaneous coronary intervention

Session: Oral abstract session: PPCI , risk factors and prevention

Topic: Pharmacotherapy

Speaker: Doctor B. Narziev (Tashkent, UZ)

Event: EuroHeartCare 2018

Congress Presentation

Add to my library

About the speaker

Doctor Bakhodir Narziev

Heart Team Clinic, Tashkent (Uzbekistan)

0 follower

7 more presentations in this session

Advancing the management of type 2 diabetes through an integrated community based cardiovascular disease prevention programme

Speaker: Ms I. Gibson (Galway, IE)

Patients' experience of risk communication after acute myocardial infarction: a meta-synthesis of qualitative studies

Speaker: Doctor S. Mentrup (Luebeck, DE)

Poor social network is associated with impaired self-rated health and symptoms of anxiety and depression across cardiac diagnoses.

Speaker: Miss A. Vinggaard Christensen (Copenhagen, DK)

Does depression affect outcomes in a clinical trial of a self-care cardiovascular disease risk reduction intervention conducted in a socioeconomically austere environment?

Speaker: Professor D. Moser (Lexington, US)

Combined use of a healthy lifestyle smartphone application and usual primary care counseling to improve arterial stiffness: A Randomized Controlled Trial (EVIDENT II Study).

Speaker: Assistant Professor J. Recio-Rodriguez (Salamanca, ES)

Access the full session

Oral abstract session: PPCI , risk factors and prevention

Speakers: Doctor B. Narziev, Ms I. Gibson, Doctor S. Mentrup, Miss A. Vinggaard Christensen, Professor D. Moser...

About the event

EuroHeartCare 2018

7 June - 9 June 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources